306 related articles for article (PubMed ID: 37779513)
1. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
Claasen MPAW; Sneiders D; Rakké YS; Adam R; Bhoori S; Cillo U; Fondevila C; Reig M; Sapisochin G; Tabrizian P; Toso C
Transpl Int; 2023; 36():11648. PubMed ID: 37779513
[TBL] [Abstract][Full Text] [Related]
2. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
4. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
5. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
Sharr WW; Chan SC; Lo CM
Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
Gunsar F
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
[TBL] [Abstract][Full Text] [Related]
7. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience.
Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
Kutlu R; Karatoprak S
J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
[TBL] [Abstract][Full Text] [Related]
9. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
Dirican A; Karakas S
J Gastrointest Cancer; 2020 Dec; 51(4):1148-1151. PubMed ID: 32839945
[TBL] [Abstract][Full Text] [Related]
10. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation.
Matevish L; Patel MS; Vagefi PA
Surg Clin North Am; 2024 Feb; 104(1):145-162. PubMed ID: 37953033
[TBL] [Abstract][Full Text] [Related]
11. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
[TBL] [Abstract][Full Text] [Related]
12. Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
Thuluvath PJ; To C; Amjad W
Am J Gastroenterol; 2021 Jan; 116(1):57-67. PubMed ID: 33110015
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
14. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
16. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
[TBL] [Abstract][Full Text] [Related]
17. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
Parikh ND; Waljee AK; Singal AG
Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
19. Current surgical treatment strategies for hepatocellular carcinoma in North America.
Khan AS; Fowler KJ; Chapman WC
World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
[TBL] [Abstract][Full Text] [Related]
20. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.
Cheung TT; Fan ST; Chan SC; Chok KS; Chu FS; Jenkins CR; Lo RC; Fung JY; Chan AC; Sharr WW; Tsang SH; Dai WC; Poon RT; Lo CM
World J Gastroenterol; 2013 May; 19(20):3083-9. PubMed ID: 23716988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]